Inogen Inc (INGN) stock
Close on Nov 17, 2026Market cap $150.87MP/E –Yield –
Earnings
Inogen's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Inogen's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 23, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026after the close | – | – | – | – | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026during market hours | $95.10M | +3.0% | -$0.14 | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 7, 2026during market hours | $85.10M | +3.4% | -$0.30 | -$0.14 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 24, 2026during market hours | $81.70M | +2.0% | -$0.26 | -$0.15 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 5, 2025before the open | $92.40M | +4.1% | -$0.20 | -$0.02 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 7, 2025during market hours | $92.30M | +3.9% | -$0.15 | -$0.02 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025during market hours | $82.30M | +5.5% | -$0.25 | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 25, 2025during market hours | $80.10M | +5.5% | -$0.41 | -$0.24 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024during market hours | $88.80M | +5.7% | -$0.25 | -$0.11 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 6, 2024during market hours | $88.80M | +6.2% | -$0.24 | -$0.07 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 7, 2024during market hours | $78.00M | +8.0% | -$0.62 | -$0.45 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 27, 2024during market hours | $75.90M | -13.8% | -$1.14 | -$0.83 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 7, 2023during market hours | $84.00M | -20.3% | -$1.97 | -$0.36 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 7, 2023during market hours | $83.60M | -19.1% | -$0.42 | -$0.25 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 4, 2023during market hours | $72.20M | -10.2% | -$0.88 | -$0.63 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 23, 2023during market hours | $88.10M | +15.3% | -$2.47 | -$0.57 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 2, 2022before the open | $105.40M | +13.2% | -$0.42 | -$0.18 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 4, 2022during market hours | $103.40M | – | – | -$0.02 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 5, 2022during market hours | $80.40M | – | -$0.62 | -$0.39 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 24, 2022during market hours | $76.40M | – | -$1.01 | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 4, 2021during market hours | $93.10M | – | $0.53 | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 4, 2021during market hours | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 4, 2021during market hours | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 24, 2021during market hours | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 4, 2020during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Inogen's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| reported revenue | FY2026 | $355.00M – $361.00M | $366.00M – $373.00M | Lowered | Aug 6, 2026 |
| reported revenueGAAP | FY2026 | $366.00M – $373.00M | – | New | Feb 24, 2026 |
| adjusted EBITDAnon-GAAP | FY2026 | $4.00M | – | New | Aug 6, 2026 |
Guidance vs results
The last range Inogen gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2026 | Revenue | $94.00M – $97.00M | $95.10M | Within range |
| FY2025 | Revenue | $354.00M – $357.00M | $348.70MΣ4Q | Below range |
| Q4 FY2025 | Revenue | $87.00M – $90.00M | $81.70M | Below range |
| Q3 FY2025 | Revenue | $91.00M – $93.00M | $92.40M | Within range |
| Q2 FY2025 | Revenue | $89.00M – $91.00M | $92.30M | Above range |
| Q1 FY2025 | Revenue | $79.00M – $81.00M | $82.30M | Above range |
| Q2 FY2024 | Revenue | $81.00M – $84.00M | $88.80M | Above range |
| Q1 FY2024 | Revenue | $73.00M – $74.00M | $78.00M | Above range |
| Q4 FY2022 | Revenue | $87.00M – $92.00M | $88.10M | Within range |
| Q3 FY2022 | Revenue | $97.00M – $100.00M | $105.40M | Above range |
Guidance history
Every forecast Inogen put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 6, 2026 | adjusted EBITDA | FY2026 | $4.00M | New |
| Aug 6, 2026 | reported revenue | FY2026 | $355.00M – $361.00M | Lowered |
| May 7, 2026 | reported revenue | FY2026 | $366.00M – $373.00M | New |
| May 7, 2026 | reported revenue | Q2 FY2026 | $94.00M – $97.00M | New |
| Feb 24, 2026 | reported revenue | FY2026 | $366.00M – $373.00M | New |
| Nov 5, 2025 | Adjusted EBITDA | FY2025 | $2.00M | New |
| Nov 5, 2025 | reported revenue | FY2025 | $354.00M – $357.00M | New |
| Nov 5, 2025 | reported revenue | Q4 FY2025 | $87.00M – $90.00M | New |
| Aug 7, 2025 | reported revenue | Q3 FY2025 | $91.00M – $93.00M | New |
| Aug 7, 2025 | reported revenue | FY2025 | $354.00M – $357.00M | Raised |
| May 7, 2025 | reported revenue | Q2 FY2025 | $89.00M – $91.00M | New |
| May 7, 2025 | revenue growth relative to the Company’s 2024 revenue | FY2025 | +5% – +6% | New |
| May 7, 2025 | reported revenue | FY2025 | $352.00M – $355.00M | Reaffirmed |
| Feb 25, 2025 | gross margin | FY2025 | 43% – 45% | New |
| Feb 25, 2025 | revenue | Q1 FY2025 | $79.00M – $81.00M | New |
| Feb 25, 2025 | revenue | FY2025 | $352.00M – $355.00M | New |
| Nov 7, 2024 | revenue growth | FY2024 | +4% – +5% | New |
| Nov 7, 2024 | revenue | FY2024 | $329.00M – $331.00M | Raised |
| Aug 6, 2024 | revenue | FY2024 | $325.00M – $330.00M | New |
| May 7, 2024 | revenue | Q2 FY2024 | $81.00M – $84.00M | New |
| Feb 27, 2024 | revenue | Q1 FY2024 | $73.00M – $74.00M | New |
| Nov 7, 2023 | Adjusted EBITDA loss | FY2023 | -$27.00M | Lowered |
| Nov 7, 2023 | revenue | FY2023 | $315.00M – $320.00M | Reaffirmed |
| Aug 7, 2023 | Adjusted EBITDA loss | FY2023 | $20.00M – $25.00M | New |
| Aug 7, 2023 | annual revenue | FY2023 | $315.00M – $320.00M | New |
| Nov 2, 2022 | revenue | Q4 FY2022 | $87.00M – $92.00M | New |
| Aug 4, 2022 | revenue | Q3 FY2022 | $97.00M – $100.00M | New |
| Feb 24, 2022 | incrementally higher material costs associated with open-market purchases of semiconductor chips | Q1 FY2022 | $4.50M – $5.50M | New |
| Nov 4, 2021 | higher material costs associated with open-market purchases of semiconductor chips | FY2021 | $5.00M – $7.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Inogen filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Update
- Results
- Update
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?